Graft Dysfunction

• CLINICAL_TRIALS research · 2026-01-20
  Clinical Trial Update: This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction [Phase 2]

  A Phase 2 clinical trial is assessing the safety and efficacy of an immune-inhibition strategy to prevent primary graft dysfunction in lung …

• CLINICAL_TRIALS research · 2025-11-17
  Clinical Trial Update: Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction [NA]

  A University Health Network study is evaluating enhanced preservation therapy to reduce transplant complications and prevent primary graft d…

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

  This clinical trial update reports a study investigating risk factors that increase the chance of developing primary graft dysfunction after…

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

  A University of Pennsylvania-led clinical trial is investigating genetic characteristics that may increase the risk of primary graft dysfunc…

• CLINICAL_TRIALS research · 2018-08-08
  Clinical Trial Update: Novartis Everolimus Transition [Phase 4]

  Clinical trial update for Everolimus transition in phase 4 completed; results posted in 2018.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2011-03-02
  Clinical Trial Update: Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung Transplantation

  This clinical trial update investigates physical and biochemical factors contributing to primary graft dysfunction after lung transplantatio…